CSX Corp (CSX)

CSX (NASDAQ:Transportation) EQUITY
$48.48
pos +0.00
+0.00%
Today's Range: 47.57 - 48.49 | CSX Avg Daily Volume: 12,202,500
Last Update: 02/24/17 - 4:00 PM EST
Volume: 0
YTD Performance: 33.34%
Open: $0.00
Previous Close: $47.73
52 Week Range: $24.01 - $49.13
Oustanding Shares: 926,446,993
Market Cap: 44,386,075,435
6-Month Chart
TheStreet Ratings Grade for CSX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 8 7 8
Moderate Buy 1 1 1 1
Hold 10 11 10 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 2 2
Mean Rec. 2.05 2.15 2.42 2.32
Latest Dividend: 0.18
Latest Dividend Yield: 1.50%
Dividend Ex-Date: 02/24/17
Price Earnings Ratio: 26.47
Price Earnings Comparisons:
CSX Sector Avg. S&P 500
26.47 26.50 30.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
37.16% 98.85% 75.37%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.30 -0.10 -0.03
Net Income -12.90 -0.10 -0.03
EPS -9.50 0.00 0.00
Earnings for CSX:
EBITDA 4.69B
Revenue 11.07B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $0.42 $0.53 $2.02 $2.25
Number of Analysts 9 8 12 11
High Estimate $0.43 $0.55 $2.14 $2.51
Low Estimate $0.41 $0.49 $1.90 $2.10
Prior Year $0.37 $0.47 $1.81 $2.02
Growth Rate (Year over Year) 14.41% 13.30% 11.79% 10.98%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Gary Morrow

 | Feb 23, 2017 | 12:00 PM EST
At risk of pullback, Norfolk Southern is particularly suspect amid weakness of peers.
RMPIA
By

Jim Cramer

 | Feb 15, 2017 | 3:34 PM EST
Some tried-and-true indicators show what's really going on with the market.
By

Bruce Kamich

 | Jan 30, 2017 | 1:52 PM EST
And likely headed higher.
By

Jim Cramer

 | Jan 30, 2017 | 12:24 PM EST
Jim Cramer says he doesn't expect CSX to do a deal if the company replaces its current CEO Michael Ward.
RMPIA
By

Jim Cramer

 | Jan 30, 2017 | 7:12 AM EST
The stocks of companies that show good fundamentals are a buy, not a sell.
By

Robert Lang

 | Jan 25, 2017 | 10:00 AM EST
This stock bolted higher on enormous turnover.

bullishCSX upgraded at BMO

Jan 23, 2017 | 7:02 AM EST
CSX was upgraded from Market Perform to Outperform, BMO Capital said. $55 price target. Activist can drive CEO change and unlock value.

bearishCSX downgraded at Deutsche

Jan 20, 2017 | 7:16 AM EST
CSX was downgraded from Buy to Hold, Deutsche Bank said. Valuation call, based on a $42 price target.
RMPIA
By

Doug Kass

 | Jan 19, 2017 | 4:13 PM EST
The U.S. dollar weakened. The price of crude oil rose by about two bits to $51.40. Gold fell by $8 to $1,203. I am buyer, to replace the half position I sold soon. Ag commodities: wheat down $0.08, corn up $0.02, soybean down $0.05 and oats up $0.01. Lumber was flat. For the second day in a row bonds got schmeissed iShares Barclays 20+ Yr Treas.Bond ETF (TLT) down over a beaner, again. (Good sale in fixed income last week!) The 10-year bond yield rose by 7 basis points to 2.46%. The long bond yield rose by 5 basis points. The 2s/10s expanded by 4 basis points to about 124 basis points. Municipals got hit and so did closed-end muni-bond funds. High yield was junky - but Blackstone / GSO Strategic Credit Fund (BGB) rose by a penny. Banks continue to be sold for a second day in a row -- despite much higher bond yields and lower bond prices. Crickets from financial bulls -- who seem to rationalize the large move this week and lack of correlation to bonds as a random act. Our "Trade of the Week" (short C) is now down by 5.5% or $3 since the trade was discussed in my Diary. Retail remains for sale. But my view is that a sentiment extreme is developing. Insurance stocks got whacked, including fav Hartford Financial (HIG) . Brokerages got hit, too. Goldman Sachs (GS) , put on Best Ideas List last week at $242, is down to $231. Biotech was lower, but not materially so (Celgene (CELG)Allergan (AGN) lower). Hwwever, spec biotech roiled to the downside (Intrexon (XON) , Ziopharm Oncology (ZIOP) , Acadia Pharmaceuticals (ACAD) , Aerie Pharmaceuticals (AERI) ). Autos mixed. Ford (F) up, General Motors (GM) down. Good for our
By

Jim Cramer

 | Jan 19, 2017 | 2:28 PM EST
As long as Mnuchin doesn't knock over the tripod.
One of the fundamental concepts of market characteristics is they generally don't go strai...
With less than an hour left in the session COP is trading below its January low. This key ...
tremendous flow here today and a big reversal candle. BOUGHT LB MAY 50 CALL AT 3.80 ...
We have a nice gainer here, let's unload it

SOLD OLED MAR 75 CALL AT 6.40 (in at 2.70)

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.